ClinConnect ClinConnect Logo
Search / Trial NCT06740084

African Youth in Mind (Y-MIND) - Pilot Feasibility Trial of a Brief Psychological Intervention for Older Adolescents with Depression Delivered Through Senior High Schools in Navrongo, Ghana

Launched by KING'S COLLEGE LONDON · Dec 17, 2024

Trial Information

Current as of April 25, 2025

Active, not recruiting

Keywords

ClinConnect Summary

The Y-MIND trial is a study designed to explore a new way to help older teenagers in Ghana who are experiencing depression. The goal is to see if a brief psychological intervention, called Y-MIND, can be effectively delivered by school guidance counselors to students aged 15 to 18 in senior high schools. In this trial, students will be randomly assigned to either receive the Y-MIND intervention, which includes support and strategies to manage their feelings, or continue with standard care, which typically involves less structured support.

To participate in the study, teenagers need to be between 15 and 18 years old, attend a senior high school in specific areas of Ghana, and have a certain level of depression as indicated by a questionnaire. They should also be able to communicate in English. Participants can expect to engage in the Y-MIND program over a period of five months, with follow-up to check on their progress. It's important to note that those currently receiving other psychological treatments or with certain mental health conditions may not be eligible for this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adolescents aged 15 to 18 years in senior high schools located within the Kassena-Nankana Municipality and Kassena-Nankana West District
  • Have scored 10 or more on the locally validated Patient Health Questionnaire-9 (PHQ-9)
  • be willing and able to be followed up for 5 months and provide informed consent or assent
  • For adolescents 15-17 years participants must have 5) access to a caregiver to obtain informed consent
  • All participants must have the ability to read, write and communicate in English language.
  • Exclusion Criteria:
  • are currently receiving any psychological treatment (talking therapy) for any common mental disorder through formal health care services
  • have active bipolar disorder or psychosis (assessed through a brief screening tool for bipolar disorder and psychosis)
  • have advanced or chronic physical illness (assessed through self-report)
  • have significant visual or hearing impairment which would interfere with their ability to take part in the study
  • are actively suicidal (assessed through the use of a four-item screening tool administered by a psychiatric nurse and reviewed by the trial clinical psychologist

About King's College London

King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.

Locations

Navrongo, , Ghana

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported